Contact us Demo our platform

Arachidic Acid

Arachidic Acid

Linear Formula

C20H40O2

Synonyms

icosanoic acid, eicosenoic acid, arachidinic acid, arachic acid

Share this metabolite

Arachidic acid, or arachic acid, is a very long-chain saturated fatty acid (VLCSFA). VLCSFAs, such as arachidic acid, behenic acid, and lignoceric acid, contain aliphatic, long fatty acid chains (the aliphatic tail) of 20, 22, and 24 carbon atoms, respectively. Arachidic acid is a minor constituent of peanuts, macadamia nuts, cocoa butter, corn oil, canola oil, and peanut oil, with its name deriving from the Latin arachis, meaning peanut. Although it is used in the production of detergents, photographic materials, and lubricants, a growing body of research suggests arachidic acid has key properties in supporting human health and reducing the risk for a variety of diseases.

Arachidic Acid and Cardiovascular Diseases

Because arachidic acid is found in a variety of nuts and oils, several studies have analyzed the impact of arachidic acid in the diet on human health. Research has shown that intake of peanuts and macadamia nuts increase VLCSFAs both in the membrane of erythrocytes (red blood cells) and systemically and are associated with a decreased risk of incident sudden cardiac arrest1. Additional research has demonstrated that increased levels of circulating arachidic acid and other VLCSFAs are associated with a lower risk of heart failure, abnormal heart rhythm, coronary heart disease, and sudden cardiac arrest2,3. Arachidic acid and other VLSFAs may therefore act as biomarkers for cardiovascular system health. Additionally, arachidic acid is a precursor to eicosanoids, long-chain fatty acids that possess anti-inflammatory and anti-clotting properties, which can help protect against cardiovascular diseases.

Arachidic Acid and Diabetes

Several studies have found that elevated levels of arachidic acid in erythrocytes and systemically are also associated with a lower risk for type 2 diabetes4, which significantly raises a person’s risk for cardiovascular disease. However, the mechanistic details of this association are at present not well understood, and more research is needed.

Arachidic Acid and Neurological Health

Recent studies have shown that arachidic acid is a fatty acid component of phosphatidylglucoside (PtdGlc). This phospholipid is found in the plasma membrane of neutrophils and is an enriched lipid in the brain. It is thought to be involved in cell-cell interactions, central nervous system signaling, and brain development. Dietary intake of the lipid PtdGlc has been associated with decreased cognitive deficits and hippocampal neuroinflammation4, and more research is being done to further elucidate the relationship between this compound and human health and disease.

The Impact of Lifestyle Factors on Circulating Arachidic Acid and Other VLCSFAs

Given the connection between circulating VLCSFA levels and cardiometabolic health, researchers have suggested that diet and other lifestyle factors may be leveraged to positively impact VLCSFA levels. A recent systemic review5 identified several important associations. Total fat and peanut intake were associated with consistently higher levels of circulating VLCSFAs; conversely, alcohol consumption had a negative impact. Physical activity also increased VLCSFAs levels, although not to the same extent as diet. While the mechanistic link is not clear, these studies suggest that generally healthier lifestyle habits may improve cardiometabolic health by increasing the circulating levels of VLCSFAs, including arachidic acid.

Metabolon’s Fatty Acids Metabolism Targeted Panel

Metabolon’s Fatty Acids Metabolism Targeted Panel measures organic compounds such as VLSFAs, including arachidic acid. Metabolon has created a suite of tools built from decades of experience across thousands of metabolomics studies to help you understand the crucial role of fatty acids and their derivatives in disorders and pathways. Contact us today to learn more about our Fatty Acids Metabolism Targeted Panel and how Metabolon can help you advance your research.

References

  1. Lemaitre RN, King IB, Rice K et al. Erythrocyte very long-chain saturated fatty acids associated with lower risk of incident sudden cardiac arrest. Prostaglandins Leukot Essent Fatty Acids. 2014; 91(4):149-53.
  2. Lemaitre RN, McKnight B, Sotoodehnia N et al. Circulating Very Long-Chain Saturated Fatty Acids and Heart Failure: The Cardiovascular Health Study. J Am Heart Assoc. 2018;7(21):e010019.
  3. Fretts AM, Mozaffarian D, Siscovick DS et al. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. J Am Heart Assoc. 2014;26;3(3):e000889.
  4. Liu Y, Liu J, Cong P et al. Exogenous phosphatidylglucoside alleviates cognitive impairment by improvement of neuroinflammation, and neurotrophin signaling. Clin Transl Med. 2021;11(3):e332.
  5. Lai KZH, Yehia NA, Semnani-Azad Z et al. Lifestyle Factors Associated with Circulating Very Long-Chain Saturated Fatty Acids in Humans: A Systematic Review of Observational Studies. Adv Nutr. 2023;14(1):99-114.
✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.